Position in CUE
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$589
-$192 QoQ
Shares Held
2,563
0.0% QoQ
Ownership
0.063%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#41
of 53 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CUE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $1,293,431,965 across 386 Biotechnology names. CUE ranks #333 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,995 | $332,670,066 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
342,763 | $113,409,991 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
142,021 | $109,731,102 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,535,737 | $99,254,679 | |
| 5 | INSM |
INSMED Inc
|
597,384 | $97,684,229 | |
| 6 | ASND |
Ascendis Pharma A/S
|
154,199 | $35,269,936 | |
| 7 | EXEL |
Exelixis, Inc.
|
687,304 | $29,478,466 | |
| 8 | ARGX |
Argenx SE
|
38,104 | $27,825,444 |
All Filings in CUE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $589 | 2,563 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $781 | 2,563 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $14,075 | 19,577 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $13,351 | 19,577 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $18,289 | 20,077 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $21,883 | 20,077 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $15,197 | 20,077 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $25,646 | 20,683 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $58,377 | 30,888 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $77,673 | 29,422 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $179,823 | 78,184 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $253,893 | 69,560 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $183,233 | 51,326 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $137,144 | 48,121 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $44,622 | 20,010 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $49,774 | 19,990 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $42,460 | 8,701 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $199,587 | 17,647 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $14,570 | 1,000 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $11,650 | 1,000 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $89,560 | 7,341 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $658,238 | 52,617 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $794,353 | 52,781 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $1,366,799 | 55,765 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $537,261 | 37,862 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||